The stock market on Friday, October 8th, 2021 is volatile due to the recent jobs report. “The U.S. economy created jobs at a much slower than expected pace in September, a pessimistic sign about the state of the economy through the total was held back substantially by a sharp drop in government employment.
Nonfarm payrolls rose by just 194,000 in the month, compared to the Dow Jones estimate of 500,000, the Labor Department reported Friday. The unemployment rate fell to 4.8%, better than the expectation for 5.1% and the lowest since February 2020.” CNBC
ChemoCentryx Announces FDA Approval of TAVNEOS™ (avacopan) in ANCA-Associated Vasculitis. “SAN CARLOS, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the U.S. Food and Drug Administration (FDA) has approved TAVNEOS (avacopan), an orally administered selective complement 5a receptor inhibitor, as an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (also known as ANCA-associated vasculitis or ANCA vasculitis), specifically granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) (the two main forms of ANCA vasculitis), in combination with standard therapy.”
“CALGARY, AB, Oct. 7, 2021 /PRNewswire/ – Sundial Growers Inc. (NASDAQ: SNDL) (“Sundial” or the “Company“) is pleased to announce today that it has entered into an arrangement agreement (the “Agreement“) with Alcanna Inc. (TSX: CLIQ) (“Alcanna“) pursuant to which Sundial will acquire all of the issued and outstanding common shares of Alcanna (“Alcanna Shares“) by way of a statutory plan of arrangement for total consideration of approximately $346 million (the “Transaction“). For more information on the announcement, a presentation deck can be found here.”